BR9708998A - Matrix metalloproteinase inhibition compound processes to inhibit matrix metalloprotease activity and to treat a mammal and matrix metalloprotease inhibition composition - Google Patents

Matrix metalloproteinase inhibition compound processes to inhibit matrix metalloprotease activity and to treat a mammal and matrix metalloprotease inhibition composition

Info

Publication number: BR9708998A
Authority: BR; Brazil
Prior art keywords: matrix; matrix metalloprotease; inhibition; mammal; treat
Prior art date: 1996-05-15

Application number

BR9708998A

Other languages

Portuguese (pt)

Inventor

Brian R Dixon

Jinshan Che

Michael C Van Zandt

David R Brittelli

Original Assignee

Bayer Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-05-15

Filing date

1997-05-12

Publication date

1999-08-03

1997-05-12 Application filed by Bayer Ag filed Critical Bayer Ag

1997-05-12 Priority claimed from PCT/US1997/007975 external-priority patent/WO1997043238A1/en

1999-08-03 Publication of BR9708998A publication Critical patent/BR9708998A/en

Links

102000005741 Metalloproteases Human genes 0.000 title 2
108010006035 Metalloproteases Proteins 0.000 title 2
230000005764 inhibitory process Effects 0.000 title 2
239000011159 matrix material Substances 0.000 title 2
241000124008 Mammalia Species 0.000 title 1
102000002274 Matrix Metalloproteinases Human genes 0.000 title 1
108010000684 Matrix Metalloproteinases Proteins 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1

BR9708998A 1996-05-15 1997-05-12 Matrix metalloproteinase inhibition compound processes to inhibit matrix metalloprotease activity and to treat a mammal and matrix metalloprotease inhibition composition BR9708998A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US86438496A	1996-05-15	1996-05-15
PCT/US1997/007975 WO1997043238A1 (en)	1996-05-15	1997-05-12	Substituted oxobutyric acids as matrix metalloprotease inhibitors

Publications (1)

Publication Number	Publication Date
BR9708998A true BR9708998A (en)	1999-08-03

Family

ID=25343155

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR9708998A BR9708998A (en)	1996-05-15	1997-05-12	Matrix metalloproteinase inhibition compound processes to inhibit matrix metalloprotease activity and to treat a mammal and matrix metalloprotease inhibition composition

Country Status (1)

Country	Link
BR (1)	BR9708998A (en)

1997
- 1997-05-12 BR BR9708998A patent/BR9708998A/en not_active Application Discontinuation

Similar Documents

Publication	Publication Date	Title
FI965156A7 (en)	1996-12-20	Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors
ATE257151T1 (en)	2004-01-15	HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS
NO972307D0 (en)	1997-05-21	matrix metalloprotease inhibitors
AR009356A1 (en)	2000-04-12	COMPOUND OF 1-4 HETEROCICLICO, METALOPROTEASE INHIBITOR AND ITS USE TO PREPARE A PHARMACEUTICAL COMPOSITION AND TO PREVENT OR TREAT A DISEASE ASSOCIATED WITH METALO PROTEASE ACTIVITY AND CAQUEXIA
ATE224364T1 (en)	2002-10-15	BETA-SULFONAMIDO HYDROXAMIC ACID AS A MATRIX METALLOPROTEINASE AND AS TACE INHIBITORS
FI962905L (en)	1996-07-19	Metalloproteinase inhibitors
DK0873312T3 (en)	2002-10-07	Alpha-substituted arylsulfonamidohydroxamic acids as TNF-alpha and matrix metalloproteinase inhibitors
EE9900371A (en)	2000-04-17	N-hydroxy-2- (alkyl-, aryl- or heteroaryl-sulfanyl-, sulfinyl- or sulfonyl) -3-substituted-alkyl-amides, -aryl-amides or -heteroaryl-amides as matrix metalloproteinase inhibitors
BR9709086A (en)	1999-08-03	Matrix metalloproteinase inhibitors having matrix metalloprotease inhibitory processes Processes to inhibit matrix metalloprotease activity in a mammal and to treat a mammal
NO20002469D0 (en)	2000-05-12	Aromatic sulfonic hydroxamic acid metalloprotease inhibitor
IL129147A0 (en)	2000-02-17	The preparation and use of ortho-sulfonamide aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
IL129148A0 (en)	2000-02-17	The preparation and use of ortho-sulfonamide aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
FI954351A7 (en)	1995-09-15	Hydroxamic acid derivatives as metalloproteinase inhibitors
TR199903287T2 (en)	2000-09-21	Matrix metalloproteinazlar�n�n ters hydroxamate inhibitors.
DE69808518D1 (en)	2002-11-07	ACE HEMMER / MATRIX METALLOPROTEINASE HEMMER-DRUG COMBINATIONS
BR9711988A (en)	1999-08-24	Matrix metalloproteinase inhibitors and their therapeutic uses
AU8858398A (en)	1999-02-08	Matrix metalloproteinase inhibitors
BR9709902A (en)	1999-08-10	Matrix metalloproteinase inhibitors
AU1836900A (en)	2000-07-24	N-carboxymethyl substituted benzolactams as inhibitors of matrix metalloproteinase
FI960482A7 (en)	1996-02-02	Matrix metalloprotease inhibitors
FI972198A7 (en)	1997-05-23	Metalloproteinase inhibitors
BR9709077A (en)	1999-08-03	Compounds inhibiting matrix metalloproteinase composition having matrix metalloprotease inhibitory processes processes to inhibit matrix metalloprotease activity and to treat a mammal
DE69819206D1 (en)	2003-11-27	matrix metalloproteinase
NO996234L (en)	2000-03-10	Spray formulations of antihyperalgesic opiates and methods for treating topical hyperalgesic conditions and itching therewith
BR9709084A (en)	1999-08-03	Matrix metalloproteinase inhibition composition having matrix metalloprotease inhibiting activity and processes for inhibiting matrix metalloprotease activity in a mammal and for treating mammals

Legal Events

Date	Code	Title	Description
2005-07-26	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2006-02-14	B11B	Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements